港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MIRXES-B

13.020

+0.0200.15%

成交量：588.28萬

成交額：7,722.46萬

市值：38.80億

市盈率：-16.93

高：13.720

開：13.700

低：12.800

收：13.000

52周最高：77.300

52周最低：12.620

股本：2.98億

香港流通股本：2.98億

量比：1.31

換手率：1.97%

股息：- -

股息率：- -

每股收益(LYR):-0.769

淨資產收益率：--

總資產收益率：-51.53%

市淨率：4.75

市盈率(LYR):-16.93

市銷率: 23.40

資料載入中...

總覽公司新聞資訊公告

每日沽空追蹤 | MIRXES-B 03月12日沽空量成交3.02萬股，沽空比例為1.61%

MIRXES-B03月11日主力淨流入172.1萬元散户資金拋售

每日沽空追蹤 | MIRXES-B 03月10日沽空量成交4.67萬股，沽空比例為1.09%

MIRXES-B03月10日遭主力拋售637.4萬元

Mirxes（2629.HK）斬獲首個政府採購訂單，胃癌無創早篩技術落地民生領域

MIRXES-B（02629）成功中標2026年濂溪區胃癌篩查與早診早治項目

MIRXES-B(02629)中標2026年濂溪區胃癌篩查和早期干預項目

MIRXES-B午前漲逾11% 近日與印度AHLL訂立諒解備忘錄以尋求進行戰略合作

港股異動丨獲政府大單，MIRXES-B拉升大漲近19%

港股異動 | MIRXES-B(02629)一度升逾18% 近日與印度AHLL訂立諒解備忘錄以尋求進行戰略合作

MIRXES-B（02629）更新2026年2月股份變動月報表，新增發行約2,188.8萬股

每日沽空追蹤 | MIRXES-B 03月04日沽空量成交1.9萬股，沽空比例為0.44%

MIRXES-B03月04日主力淨流出337.4萬元散户資金買入

MIRXES-B盤中異動下午盤快速跳水5.01%

每日沽空追蹤 | MIRXES-B 03月02日沽空量成交1.54萬股，沽空比例為0.44%

MIRXES(02629.HK)與Apollo附屬訂立諒解備忘錄研發癌症早期檢測解決方案

阿斯达克财经

Mirxes Holding Co Ltd - 合資公司將探索從癌症檢測擴展至其他預防與精準醫療診斷領域

每日沽空追蹤 | MIRXES-B 02月26日沽空量成交5.8萬股，沽空比例為1.23%

MIRXES-B02月25日遭主力拋售247.3萬元

Mirxes（02629.HK）管線重大突破，亞洲結直腸癌將進入「一管血時代」

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02629/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":13.02,"timestamp":1774339700004,"preClose":13,"halted":0,"volume":5882800,"delay":0,"changeRate":0.0015384615384615057,"floatShares":298000000,"shares":298000000,"eps":-0.76899,"marketStatus":"未開盤","change":0.02,"latestTime":"03-24 16:08:20","open":13.7,"high":13.72,"low":12.8,"amount":77224602,"amplitude":0.070769,"askPrice":13.08,"askSize":12000,"bidPrice":13.02,"bidSize":9600,"shortable":3,"etf":0,"ttmEps":-2.006,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":13,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":1.3131015517580042,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":298000000,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":1.3131015517580042,"shares":298000000,"dividePrice":0,"high":13.72,"amplitude":0.070769,"preClose":13,"low":12.8,"week52Low":12.62,"pbRate":"4.75","psRate":"23.40","week52High":77.3,"institutionHeld":0,"latestPrice":13.02,"committee":-0.111111,"eps":-0.76899,"divideRate":0,"volume":5882800,"delay":0,"ttmEps":-2.006,"open":13.7,"prevYearClose":44.04,"prevWeekClose":13.06,"prevMonthClose":16.96,"prevQuarterClose":44.04,"fiveDayClose":13.84,"twentyDayClose":18,"sixtyDayClose":47.36,"earningDate":1774886400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null},{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1762531200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2026-03-23","current":-6.490528,"percent":1,"low":-34.231253,"twenty":-24.886506,"median":-17.290049,"eighty":-11.128301,"high":-6.42621,"avg":-18.063583,"sd":7.682223,"marketCap":3837407821},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-29","current":-19.927844,"twenty":-12.534962,"median":-11.42267,"eighty":-10.837215,"marketCap":11841524145},{"date":"2025-09-05","current":-19.639174,"twenty":-15.876379,"median":-11.649361,"eighty":-10.890619,"marketCap":11678374256},{"date":"2025-09-12","current":-19.500462,"twenty":-16.755738,"median":-11.763715,"eighty":-10.953665,"marketCap":11578379164},{"date":"2025-09-19","current":-23.413745,"twenty":-18.486553,"median":-11.918008,"eighty":-11.048541,"marketCap":13880897747},{"date":"2025-09-26","current":-25.667378,"twenty":-19.506384,"median":-11.983928,"eighty":-11.09201,"marketCap":15222937150},{"date":"2025-10-03","current":-33.789751,"twenty":-19.751895,"median":-12.054377,"eighty":-11.092062,"marketCap":20046350866},{"date":"2025-10-10","current":-31.081374,"twenty":-21.012535,"median":-12.217733,"eighty":-11.099357,"marketCap":18433897286},{"date":"2025-10-17","current":-30.795303,"twenty":-24.490925,"median":-12.444526,"eighty":-11.135571,"marketCap":18242589234},{"date":"2025-10-24","current":-29.480903,"twenty":-26.341784,"median":-12.526178,"eighty":-11.168279,"marketCap":17463692166},{"date":"2025-10-31","current":-31.356875,"twenty":-27.937945,"median":-12.547947,"eighty":-11.182791,"marketCap":18570545895},{"date":"2025-11-07","current":-29.443096,"twenty":-29.330719,"median":-14.698348,"eighty":-11.200916,"marketCap":17450027305},{"date":"2025-11-14","current":-27.638699,"twenty":-29.330719,"median":-16.088166,"eighty":-11.200931,"marketCap":16370503298},{"date":"2025-11-21","current":-24.184396,"twenty":-29.304437,"median":-16.756842,"eighty":-11.200931,"marketCap":14348103892},{"date":"2025-11-28","current":-24.195214,"twenty":-29.187935,"median":-17.63001,"eighty":-11.23741,"marketCap":14348103892},{"date":"2025-12-05","current":-23.772189,"twenty":-29.148423,"median":-18.890444,"eighty":-11.255378,"marketCap":14102136397},{"date":"2025-12-12","current":-23.497248,"twenty":-28.889741,"median":-19.500462,"eighty":-11.255392,"marketCap":13938158067},{"date":"2025-12-19","current":-21.712097,"twenty":-28.67677,"median":-19.631135,"eighty":-11.255421,"marketCap":12877764865},{"date":"2025-12-24","current":-21.246317,"twenty":-28.57994,"median":-19.827042,"eighty":-11.29025,"marketCap":12593535759},{"date":"2026-01-02","current":-19.80807,"twenty":-28.28441,"median":-19.927844,"eighty":-11.319302,"marketCap":11751780331},{"date":"2026-01-09","current":-20.890071,"twenty":-27.925151,"median":-19.877443,"eighty":-11.34983,"marketCap":12407693651},{"date":"2026-01-16","current":-19.081786,"twenty":-27.799056,"median":-19.827042,"eighty":-11.390654,"marketCap":11341834505},{"date":"2026-01-23","current":-18.852127,"twenty":-27.479942,"median":-19.808337,"eighty":-11.410801,"marketCap":11205185897},{"date":"2026-01-30","current":-15.599054,"twenty":-27.063835,"median":-19.623095,"eighty":-11.479217,"marketCap":9281173489},{"date":"2026-02-06","current":-11.745627,"twenty":-26.682281,"median":-19.522615,"eighty":-11.564037,"marketCap":6995889642},{"date":"2026-02-13","current":-10.948036,"twenty":-26.176649,"median":-19.485003,"eighty":-11.479217,"marketCap":6523593295},{"date":"2026-02-20","current":-11.635464,"twenty":-25.842912,"median":-19.423136,"eighty":-11.535764,"marketCap":6930948895},{"date":"2026-02-27","current":-8.395221,"twenty":-25.669111,"median":-19.104899,"eighty":-11.369937,"marketCap":5006341280},{"date":"2026-03-06","current":-7.555123,"twenty":-25.521048,"median":-19.048406,"eighty":-11.255389,"marketCap":4501574559},{"date":"2026-03-13","current":-7.025416,"twenty":-25.121158,"median":-18.685364,"eighty":-11.200928,"marketCap":4191630081},{"date":"2026-03-20","current":-6.456636,"twenty":-24.915271,"median":-17.63001,"eighty":-11.157381,"marketCap":3855118934},{"date":"2026-03-23","current":-6.42621,"twenty":-24.886506,"median":-17.290049,"eighty":-11.128301,"marketCap":3837407821}],"updateTime":1774343501917},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618133759","title":"每日沽空追蹤 | MIRXES-B 03月12日沽空量成交3.02萬股，沽空比例為1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618133759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618133759?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 16:30","pubTimestamp":1773304233,"startTime":"0","endTime":"0","summary":"MIRXES-B北京时间03月12日，跌1.09%，卖空量成交3.02万股，较上一交易日减少69.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163440a6ba51e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163440a6ba51e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2618976207","title":"MIRXES-B03月11日主力淨流入172.1萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618976207?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 16:16","pubTimestamp":1773216963,"startTime":"0","endTime":"0","summary":"03月11日, MIRXES-B股价涨0.27%，报收14.74元，成交金额7198.2万元，换手率1.65%，振幅5.44%，量比0.71。MIRXES-B今日主力资金净流入172.1万元，上一交易日主力净流出637.4万元。该股近5个交易日上涨5.43%，主力资金累计净流出2067.4万元；近20日主力资金累计净流出3633.9万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162156a460acaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162156a460acaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2618285997","title":"每日沽空追蹤 | MIRXES-B 03月10日沽空量成交4.67萬股，沽空比例為1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618285997","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618285997?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 16:30","pubTimestamp":1773131433,"startTime":"0","endTime":"0","summary":"MIRXES-B北京时间03月10日，跌0.74%，卖空量成交4.67万股，较上一交易日增加9.37%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163433a45df88f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163433a45df88f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2618997283","title":"MIRXES-B03月10日遭主力拋售637.4萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618997283","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618997283?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 16:15","pubTimestamp":1773130537,"startTime":"0","endTime":"0","summary":"03月10日, MIRXES-B股价跌0.74%，报收14.70元，成交金额6500.8万元，换手率1.48%，振幅5.94%，量比0.66。MIRXES-B今日主力资金净流出637.4万元，连续5日净流出，上一交易日主力净流出104.1万元。该股近5个交易日下跌2.95%，主力资金累计净流出2576.9万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出5833.1万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161743a6b4c66e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161743a6b4c66e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2617716395","title":"Mirxes（2629.HK）斬獲首個政府採購訂單，胃癌無創早篩技術落地民生領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2617716395","media":"美港探案","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617716395?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 18:07","pubTimestamp":1772705275,"startTime":"0","endTime":"0","summary":"根据公司于3月5日盘后的公告，这是Mirxes成立以来的第一个公共卫生癌症早筛项目，也是其在中国的第一个政府采购项目，标志着其miRNA液体活检技术正式进入公共卫生体系，为胃癌早筛的规模化落地奠定关键基础。此次中标，反映了公共卫生领域权威对Mirxes技术实力与产品价值的重要认可。Mirxes的无创技术恰好为当地政府提供了切实可行的解决方案。值得强调的是，这仅仅是Mirxes拿下的第一个政府民生项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305181226a44f5f96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305181226a44f5f96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1105145978","title":"MIRXES-B（02629）成功中標2026年濂溪區胃癌篩查與早診早治項目","url":"https://stock-news.laohu8.com/highlight/detail?id=1105145978","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105145978?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 16:37","pubTimestamp":1772699830,"startTime":"0","endTime":"0","summary":"MIRXES-B（02629）近日宣布，公司已成功中标2026年濂溪区胃癌筛查与早期干预项目。这一重要成果标志着公司在癌症早筛领域的专业能力与市场竞争力获得权威认可，为其未来业务拓展奠定了坚实基础。\n该项目旨在通过先进的筛查技术，实现胃癌的早期发现与及时干预，从而有效提升区域居民健康水平。MIRXES-B凭借其创新的检测方案与丰富的项目经验，在竞标中脱颖而出，展现了企业在精准医疗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2617514706","title":"MIRXES-B(02629)中標2026年濂溪區胃癌篩查和早期干預項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2617514706","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617514706?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 16:34","pubTimestamp":1772699688,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MIRXES-B 发布公告，于2026年3月3日，公司成功中标2026年濂溪区胃癌筛查和早期干预项目，这是公司首个公共卫生癌症早筛项目，也是其在中国首个政府采购项目，标志着其miRNA液体活检技术正式进入公共卫生体系，为胃癌早筛规模化落地奠定关键基础。该项目预算金额人民币810.0万元，最高投标价人民币769.5万元，将为中国江西九江濂溪区约3万名居民提供胃癌早筛服务。预期该项目将提升当地胃癌早期检出率，加强地区癌症防控架构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MIRXES-B(02629)中标2026年濂溪区胃癌筛查和早期干预项目","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2617592981","title":"MIRXES-B午前漲逾11% 近日與印度AHLL訂立諒解備忘錄以尋求進行戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2617592981","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617592981?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 12:00","pubTimestamp":1772683208,"startTime":"0","endTime":"0","summary":"近日，MIRXES-B发布公告，本公司已与Apollo Health and Lifestyle Limited订立谅解备忘录以寻求进行战略合作，从而于印度及邻近国家共同开发及商业化先进的癌症早期检测解决方案。Apollo同时亦被誉为印度顶尖的癌症治疗机构，致力透过创新方法成为全球早期疾病检测及预防领域的核心参与者。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/03/05120056189227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02629","MNDmain","BK1161"],"gpt_icon":0},{"id":"2617599779","title":"港股異動丨獲政府大單，MIRXES-B拉升大漲近19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617599779","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617599779?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 10:57","pubTimestamp":1772679421,"startTime":"0","endTime":"0","summary":"MIRXES-B盘初大幅拉升，一度脏近19%，报16.63港元，截至目前成交超8000万港元。　　另外，MIRXES-B还曾在2月底公布，公司已完成CADENCE  CRC的入组程序。该研究是一项大型前瞻性临床研究，旨在验证其血液检测在平均风险及高风险成人群体中筛查结直肠癌的有效性。　　还值得注意的是，MIRXES-B还宣布已与Apollo Health and Lifestyle Limited订立谅解备忘录以寻求进行战略合作，从而于印度及邻近国家共同开发及商业化先进的癌症早期检测解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260305/32046297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","VT","02629","BK4585","BK1161","VXUS"],"gpt_icon":0},{"id":"2617599958","title":"港股異動 | MIRXES-B(02629)一度升逾18% 近日與印度AHLL訂立諒解備忘錄以尋求進行戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2617599958","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617599958?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 10:48","pubTimestamp":1772678935,"startTime":"0","endTime":"0","summary":"消息面上，近日，MIRXES-B发布公告，本公司已与Apollo Health and Lifestyle Limited订立谅解备忘录以寻求进行战略合作，从而于印度及邻近国家共同开发及商业化先进的癌症早期检测解决方案。Apollo同时亦被誉为印度顶尖的癌症治疗机构，致力透过创新方法成为全球早期疾病检测及预防领域的核心参与者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MNDmain","VXUS","BK4585","02629","BK4588","VT","BK1161"],"gpt_icon":0},{"id":"1179695378","title":"MIRXES-B（02629）更新2026年2月股份變動月報表，新增發行約2,188.8萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=1179695378","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179695378?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 09:06","pubTimestamp":1772672760,"startTime":"0","endTime":"0","summary":"2026年3月5日，MIRXES-B发布2026年2月股份变动月报表。报告期为2026年2月1日至2026年2月28日，法定股本维持10,000,000,000股，无变动。报告显示，截至2月底，公司已发行普通股由1月底的276,342,331股增至298,230,331股，当月新增发行21,888,000股。目前公司已确认符合香港联交所对上市公司公众持股量的要求。月报还披露，公司继续遵守相关法律法规及香港联交所《上市规则》要求。该份月报由执行董事兼首席执行官周礪寒博士签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2616551035","title":"每日沽空追蹤 | MIRXES-B 03月04日沽空量成交1.9萬股，沽空比例為0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616551035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616551035?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 16:30","pubTimestamp":1772613032,"startTime":"0","endTime":"0","summary":"MIRXES-B北京时间03月04日，跌8.2%，卖空量成交1.9万股，较上一交易日减少74.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163447a6a15023&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163447a6a15023&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2616299587","title":"MIRXES-B03月04日主力淨流出337.4萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616299587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616299587?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 16:15","pubTimestamp":1772612118,"startTime":"0","endTime":"0","summary":"03月04日, MIRXES-B股价跌8.20%，报收13.99元，成交金额6105.7万元，换手率1.44%，振幅10.70%，量比1.03。MIRXES-B今日主力资金净流出337.4万元，上一交易日主力净流入174.7万元。该股近5个交易日下跌20.06%，主力资金累计净流入2032.1万元；近20日主力资金累计净流出3653.3万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161559a44a5886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161559a44a5886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2616831989","title":"MIRXES-B盤中異動 下午盤快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616831989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616831989?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 14:08","pubTimestamp":1772518107,"startTime":"0","endTime":"0","summary":"2026年03月03日下午盘14时08分，MIRXES-B股票出现波动，股价急速下跌5.01%。截至发稿，该股报15.350港元/股，成交量216.18万股，换手率0.72%，振幅5.01%。MIRXES-B股票所在的生物技术行业中，整体跌幅为3.69%。MIRXES-B公司简介：MiRXES Holding Company Limited 是一家微型核糖核酸技术公司,专注于癌症早期检测和精准医疗。GASTROClear 是一种基于血液的 miRNA 检测面板,包括 12 个用于胃癌筛查的 miRNA 生物标记物。LUNGClear 是公司的肺癌筛查候选产品,是一个由在多中心研究中发现并验证的 miRNA 生物标志物组成的检测面板。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603031408279542bc32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603031408279542bc32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2616631983","title":"每日沽空追蹤 | MIRXES-B 03月02日沽空量成交1.54萬股，沽空比例為0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616631983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616631983?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:30","pubTimestamp":1772440235,"startTime":"0","endTime":"0","summary":"MIRXES-B北京时间03月02日，跌4.72%，卖空量成交1.54万股，较上一交易日减少80.28%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163522a44151ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163522a44151ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2614015616","title":"MIRXES(02629.HK)與Apollo附屬訂立諒解備忘錄 研發癌症早期檢測解決方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2614015616","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614015616?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:53","pubTimestamp":1772095980,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629.HK) 公布，与Apollo全资附属公司Apollo Health and Lifestyle Limited(AHLL)订立谅解备忘录，以寻求进行战略合作，从而于印度及邻近国家共同开发及商业化先进的癌症早期检测解决方案。公司预料，将会于印度创立一家合营公司，根据公司及Apollo将注入的知识产权、临床管线、研发、临床试验基础设施及商业渠道，其股权价值将不少于5,000万美元。(ca/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-02-26 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250605150733578_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250605150733578_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505173/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505173/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"1191555003","title":"Mirxes Holding Co Ltd - 合資公司將探索從癌症檢測擴展至其他預防與精準醫療診斷領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1191555003","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191555003?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:51","pubTimestamp":1772095871,"startTime":"0","endTime":"0","summary":"MIRXES-B宣布，其合资公司将积极探索业务拓展方向，计划在现有癌症检测业务基础上，向更广泛的预防性及精准医疗诊断领域延伸。这一战略布局旨在通过技术升级和服务多元化，提升公司在全球医疗诊断市场的影响力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2614014927","title":"每日沽空追蹤 | MIRXES-B 02月26日沽空量成交5.8萬股，沽空比例為1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614014927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614014927?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 16:30","pubTimestamp":1772094632,"startTime":"0","endTime":"0","summary":"MIRXES-B北京时间02月26日，跌1.54%，卖空量成交5.8万股，较上一交易日减少14.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163459a4cab62f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163459a4cab62f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2614069485","title":"MIRXES-B02月25日遭主力拋售247.3萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614069485","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614069485?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 16:15","pubTimestamp":1772007349,"startTime":"0","endTime":"0","summary":"02月25日, MIRXES-B股价跌2.78%，报收17.50元，成交金额6374.3万元，换手率1.22%，振幅6.72%，量比0.92。MIRXES-B今日主力资金净流出247.3万元，上一交易日主力净流出3615.0万元。该股近5个交易日下跌20.59%，主力资金累计净流出4096.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出6298.1万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161942a71d4a12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161942a71d4a12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2613678374","title":"Mirxes（02629.HK）管線重大突破，亞洲結直腸癌將進入「一管血時代」","url":"https://stock-news.laohu8.com/highlight/detail?id=2613678374","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613678374?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 18:09","pubTimestamp":1771841398,"startTime":"0","endTime":"0","summary":"觅瑞 CADENCE CRC 研究的完成，以及结直肠癌血液早筛产品的即将落地，意味着亚洲人终于有了一款基于本土人群临床数据、量身定制的无创结直肠癌血液早筛产品。","market":"fut","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3880399","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","02629"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":118,"code":"91000000","status":"200"}]}}